Correlation Engine 2.0
Clear Search sequence regions


  • female (1)
  • ivermectin (10)
  • lactones (1)
  • Sizes of these terms reflect their relevance to your search.

    The management of equine strongyles has become problematic over the last decade because of an increased prevalence of drug-resistant isolates worldwide. Therapeutic options are therefore limited, leaving macrocyclic lactones as the most often effective drug class. However, their lipophilic properties result in a long-lasting elimination that could favour drug resistance selection. As a result, ivermectin treatment in lactating mares could promote suboptimal exposure of their foal parasites to ivermectin, thereby selecting for more resistant worms. To test for this putative transfer, we selected two groups of six foal-mare pairs, one group of mares receiving ivermectin and the other being left untreated. We compared faecal egg count trajectories in foals from the two groups and quantified plasma ivermectin concentrations in ivermectin treated mares and their foals during seven days. Our results showed limited but sustained plasmatic exposure of foals associated with non-significant faecal egg count reduction (P = 0.69). This suggests that ivermectin treatment in lactating mares results in suboptimal exposure to the drug in their foal. Copyright © 2021 Elsevier B.V. All rights reserved.

    Citation

    Ghismon-de-Kasin Mayinda, Delphine Serreau, Amandine Gesbert, Fabrice Reigner, Jean-François Sutra, Anne Lespine, Guillaume Sallé. Ivermectin treatment in lactating mares results in suboptimal ivermectin exposure in their suckling foals. Veterinary parasitology. 2021 Aug;296:109511

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34237517

    View Full Text